- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05056545
Postpartum Family Planning Program in Rwanda
Implementation and Evaluation of a Large-scale Postpartum Family Planning Program in Rwanda
Study Overview
Detailed Description
In 2017-2018, the study team worked closely with the Rwanda Ministry of Health (MOH) to develop and pilot test a theory-based, multi-level intervention targeting postpartum family planning (PPFP) supply and demand in 4 government health facilities in Kigali, the capital. This innovative PPFP intervention was informed by clients, clinic providers, champions, and Community Health Workers. Long-acting reversible contraceptives (LARC), the intrauterine device (PPIUD) and implant, are fundamental to PPFP programs. LARCs are highly effective and are the only reversible methods that may be safely used in early postpartum period by breastfeeding women. During the pilot, LARC uptake among postpartum women increased significantly (172% for PP implant, 2,687% for PPIUD), PPFP feasibility and acceptability were high among providers and clients, and side-effects were rare.
The study team now proposes to use an implementation science framework to evaluate the effectiveness of different PPFP demand creation strategies and test the hypothesis that our PPFP intervention is adaptable to large-scale implementation, cost-effective, and sustainable. In a Type 2 effectiveness-implementation hybrid study, we will evaluate facility organizational readiness prior to implementing the PPFP intervention in a clinic randomized trial in 10 high-volume health facilities in Kigali, Rwanda (Aim 1). Adaptability and sustainability within government facilities is a critical aspect of the proposal, and the MOH and other local stakeholders will be engaged from the outset. It is expected that this project will deliver PPFP counseling to over 21,000 women/couples during the project period. They will then evaluate the PPFP intervention effectiveness and implementation processes using RE-AIM (Aim 2). The team hypothesizes that the PPFP intervention will significantly increase the number of stakeholders engaged, PPFP providers and promoters, couples/clients receiving information about PPFP (reach), and LARC uptake (effectiveness) comparing intervention versus standard of care. It is expected that PPFP client satisfaction will be high and side-effects will be rare. The independent effectiveness of each demand creation strategy on LARC uptake will be estimated. Assessment of measures of PPFP intervention adoption, implementation, and maintenance at the patient-, provider- and stakeholder-level to assess PPFP intervention sustainability will be completed by the study team. Finally, this project will evaluate PPFP intervention cost-effectiveness and develop a national costed implementation plan to guide Rwandan MOH decision-making for nationwide roll-out of PPFP services (Aim 3). This trial hypothesizes that the PPFP intervention will be cost-saving relative to standard of care.
This intervention represents an important contribution to the Rwanda Family Planning 2020 goals and the MOH are enthusiastic to see our successful pilot efforts expanded to a larger number of facilities for greater and sustained impact. The new PPFP implementation model is designed to be replicable and expandable to other countries in the region which similarly have high unmet need for PPFP.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kristin Wall, PhD
- Phone Number: 404-727-9088
- Email: kmwall@emory.edu
Study Contact Backup
- Name: Amanda Tichacek, MPH
- Phone Number: 404-727-7776
- Email: amanda.tichacek@emory.edu
Study Locations
-
-
Kigali Province
-
Kigali, Kigali Province, Rwanda
- Recruiting
- Project San Francisco, Kigali
-
Contact:
- Etienne Karita, MD
- Phone Number: +250 252 503 233
- Email: ekarita@rzhrg-mail.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Eligible PPFP promoters will be government facility providers working in ANC,L&D, IV and/or postpartum services at one of the study facilities.
- Eligible PPFP providers will be government facility providers working in L&D, and/or family planning services at one of the study facilities.
- Eligible Happy Client promotors will be postpartum women who received promotions and selected a PPFP method.
- Eligible nurse/midwife and CHW promotors will be women working as nurses or CHWs at one of the intervention facilities.
- All women eligible for PPFP services in this study will be at any stage of pregnancy or up to 14 weeks postpartum, and receiving antenatal care (ANC), L&D, IV, or postpartum services at one of the intervention or pilot facilities
Exclusion Criteria:
- Prisoners
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PPFP Intervention
The study team will train government clinic staff in ANC, L&D, IV, or postpartum services to promote and provide the PPFP intervention at the selected facilities.
Community Health Workers (CHW) and 'Happy Clients' will be trained as PPFP promotional agents.
Video-based PPFP promotions will be shown at the intervention facilities.
If interested in PPFP, women will be referred to the facility by their CHW.
|
C4 Intervention, is an innovative form of Post Partum Family Planning (PPFP). PPFP methods include: the copper intrauterine device, hormonal implant, tubal ligation, and (after 6 weeks post-partum in breastfeeding women) Depo-Provera and oral contraceptive pills. These are provided as current, standard of care in Rwanda, are procured by the government, and administered by trained nurses and doctors. The C4 training will occur at the 4 pilot facilities. Training will include a 2-day didactic session covering PPFP provision, follow-up, use of the C4 counseling flipchart; mock counseling sessions; and PPIUD and PP implant insertion and removal trainings. The study team will train government clinic staff in family planning, ANC, L&D, and IV to promote C4 at the selected facilities. 'Happy Clients' will be recruited from women who received promotions and selected PPFP to join a clinic-based PPFP promotions team. Women interested in PPFP will be referred to the facility by their CHW. |
No Intervention: Standard of Care
Currently, no systematic PPFP training, promotional, or service delivery activities are regularly taking place at the selected facilities.
The team will compare the intervention with historical records from the facilities applying intervention and compare
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numbers of clinic directors engaged
Time Frame: Through study completion, an average of 3 years
|
Numbers of clinic directors engaged to provide the PPFP Intervention
|
Through study completion, an average of 3 years
|
Number of Nurses trained to promote PPFP
Time Frame: After completion of a 2-day training
|
The number of nurses who complete PPFP intervention session to promote PPFP use
|
After completion of a 2-day training
|
Number of CHWs trained to promote PPFP
Time Frame: After completion of a 2-day training session
|
The number of CHWs who complete C4 training session to promote PPFP use
|
After completion of a 2-day training session
|
Number of providers trained to provide PPFP
Time Frame: After completion of a 2-day training session
|
Nurses and midwives working labor and delivery and family planning will attend a 2-day didactic training session.
Providers will complete a post-training test consisting of 10 true or false questions.
Those who do not score at least 80% on the post-training test will be offered re-training after one week.
|
After completion of a 2-day training session
|
Number of providers certified to provide PPFP
Time Frame: After completion of a 2-day training session
|
After completing the didactic training, providers will have the opportunity to become certified, by correctly inserting 5 PPIUDs and 5 PP implants under supervision.
|
After completion of a 2-day training session
|
Number of promotions to pregnant or postpartum women/couples
Time Frame: Beginning at the first antenatal care visit up to post-partum week 14 (up to 54 weeks)
|
The number of pregnant or postpartum women/couples receiving one-on-one C4 counseling
|
Beginning at the first antenatal care visit up to post-partum week 14 (up to 54 weeks)
|
Number of PPIUD insertions
Time Frame: Up to postpartum week 14
|
The number of postpartum women who opt to have a PPIUD inserted
|
Up to postpartum week 14
|
Number of PP implant insertions
Time Frame: Up to postpartum week 14
|
The number of postpartum women who opt to have a PP implant inserted.
|
Up to postpartum week 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost-effectiveness/cost-utility: Couple Years Protection (CYP)
Time Frame: Years 2 and 4 of the project period
|
Cost, in US dollars adjusted for the year of data analysis per CYP
|
Years 2 and 4 of the project period
|
Cost-effectiveness/cost-utility: Cost per Quality Adjusted life years (QALY)
Time Frame: Years 2 and 4 of the project period
|
Cost, in US dollars adjusted for the year of data analysis of cost per QALY saved
|
Years 2 and 4 of the project period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kristin Wall, PhD, Emory University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00002354
- R01HD101600 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Family Planning
-
Jacaranda HealthHarvard School of Public Health (HSPH); Jhpiego; IPSOSRecruitingPostpartum Family PlanningKenya
-
Saint-Joseph UniversityRecruitingFamily Planning ServicesLebanon
-
RANDMakerere UniversityNot yet recruitingFamily Planning
-
University of California, San DiegoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Boston UniversityUnited States Agency for International Development (USAID); Pharmaceutical...Completed
-
Addis Ababa UniversityUnknown
-
University of California, San FranciscoPopulation Services InternationalCompleted
-
Assiut UniversityCompleted
-
Instituto Materno Infantil Prof. Fernando FigueiraCompleted
-
Stanford UniversityCompletedPostpartum Contraception | Family PlanningUnited States
Clinical Trials on C4 Intervention
-
Timothy MullettMerck Sharp & Dohme LLCRecruitingCancer | Health Care UtilizationUnited States
-
Baxter Healthcare CorporationGambro Renal Products, Inc.Completed
-
Texas A&M UniversityNutraboltCompletedExercise Ergogenics
-
Baxter Healthcare CorporationUniversity of Louisville; Gambro Renal Products, Inc.CompletedChronic Kidney Disease | Chronic Renal DiseaseUnited States
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...Lederle-Praxis BiologicalsCompletedHIV InfectionsUnited States
-
Marmara UniversityNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
Texas A&M UniversityNutraboltCompleted
-
Texas A&M UniversityNutraboltCompletedDietary Modification